[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ildong Pharmaceutical Co Ltd (000230) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

October 2018 | 30 pages | ID: I27414F3EC2EN
GlobalData

US$ 250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Ildong Pharmaceutical Co Ltd (IPC) is a manufacturer of pharmaceutical products. The company offers finished drugs, health foods and foods, raw material drugs, cosmetics and medical devices and others. Its raw material drugs comprise synthesis, probiotics, vitamins and biometabolites. IPC also offers finished drugs such as anti-histamine drugs, antineoplastic agents, antifungals and antivirals, blood circulation, endocrine and metabolic system, cardiovascular system, central nervous system, gastrointestinal system, respiratory system, topical preparation, urogenital system and other products. The company operates plants in Gyeonggi-do, Chungcheongbuk-do, and others. It markets its products in South Korea and abroad. IPC is headquartered in Seoul, South Korea.

Ildong Pharmaceutical Co Ltd (000230) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details
Partnerships
CoLucid Pharma And Ildong Pharma Enter Into Distribution Agreement For Lasmiditan
Bayer Enters Into Co-Marketing Agreement With Ildong Pharma For OTC Drugs
Arena Pharma Enters Into Co-Marketing Agreement With Ildong Pharma For Belviq
Ildong Pharma Enters Into Co-Promotion Agreement With Pfizer Pharma For Generic Drugs
Licensing Agreements
Arena Pharma Enters Into Licensing And Co-Development Agreement With Ildong Pharma For Temanogrel
TG Therapeutics Enters Into Licensing Agreement With Ildong Pharma For Ublituximab
Ferrer Enters Into Licensing Agreement With Ildong Pharma For Lorediplon
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir
Equity Offering
AntriaBio Raises USD4.5 Million in Private Placement of Shares
Ildong Pharma to Raise USD85 Million in Public Offering
Acquisition
Green Cross Acquires Additional 7.07% Stake In Ildong Pharma From WhanIn Pharma
Ildong Pharmaceutical Co Ltd - Key Competitors
Ildong Pharmaceutical Co Ltd - Key Employees
Ildong Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Product News
Jul 09, 2018: Local drug makers strive to conquer neurological diseases
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
CoLucid Pharma And Ildong Pharma Enter Into Distribution Agreement For Lasmiditan
Bayer Enters Into Co-Marketing Agreement With Ildong Pharma For OTC Drugs
Arena Pharma Enters Into Co-Marketing Agreement With Ildong Pharma For Belviq
Ildong Pharma Enters Into Co-Promotion Agreement With Pfizer Pharma For Generic Drugs
Arena Pharma Enters Into Licensing And Co-Development Agreement With Ildong Pharma For Temanogrel
TG Therapeutics Enters Into Licensing Agreement With Ildong Pharma For Ublituximab
Ferrer Enters Into Licensing Agreement With Ildong Pharma For Lorediplon
Ildong Enters Into Licensing Agreement With LG Life Sciences For Factive, Oral Quinolone Antibiotic
Ildong Enters Into Licensing Agreement With Ajinomoto Pharma For Cilnidipine/Valsartan Drug
LG Life Sciences Enters Into Licensing Agreement With Ildong Pharma For Besifovir
AntriaBio Raises USD4.5 Million in Private Placement of Shares
Ildong Pharma to Raise USD85 Million in Public Offering
Green Cross Acquires Additional 7.07% Stake In Ildong Pharma From WhanIn Pharma
Ildong Pharmaceutical Co Ltd, Key Competitors
Ildong Pharmaceutical Co Ltd, Key Employees
Ildong Pharmaceutical Co Ltd, Other Locations

LIST OF FIGURES

Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Ildong Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018


More Publications